Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-20 of 51

Sort by

Sort Order Select

Journal Articles

Abstract 5541: BGB-15025, a potent and selective HPK1 inhibitor, is efficacious as a single agent or in combination with PD-1 antibody in multiple tumor models

Ye Liu, Jing Li, Zhuo Li, Qin Wang, Xing Zhou, Xiaoxin Liu, Bo Zhang, Xitao Wang, Sanjia Xu, Hanzi Sun, Xiaomin Song, Xi Yuan, Zhiwei Wang, Xuesong Liu

Cancer Res (2022) 82 (12_Supplement): 5541.

https://doi.org/10.1158/1538-7445.AM2022-5541

Published: 15 June 2022

View article titled, Abstract 5541: BGB-15025, a potent and selective HPK1 inhibitor, is efficacious as a single agent or in combination with PD-1 antibody in multiple tumor models

Journal Articles

Abstract 3077: Preclinical characterization of BGB-11417, a potent and selective Bcl-2 inhibitor with superior antitumor activities in haematological tumor models

Cancer Res (2020) 80 (16_Supplement): 3077.

https://doi.org/10.1158/1538-7445.AM2020-3077

Published: 15 August 2020

View article titled, Abstract 3077: Preclinical characterization of BGB-11417, a potent and selective Bcl-2 inhibitor with superior antitumor activities in haematological tumor models

Journal Articles

Abstract 664: BGB-10188, a highly selective PI3Kδ inhibitor with improved safety profile and superior anti-tumor activities in vivo

Xiao Yang, Xiaolong Yang, Xinxin Cui, Dan Su, Yue Wu, Xuebing Sun, Jingyuan Wang, Huichen Bai, Wei Wei, Jing Li, Xi Yuan, Ye Liu, Fan Wang, Zhiwei Wang, Lai Wang, Xuesong Liu, Xiaomin Song

Cancer Res (2020) 80 (16_Supplement): 664.

https://doi.org/10.1158/1538-7445.AM2020-664

Published: 15 August 2020

View article titled, Abstract 664: BGB-10188, a highly selective PI3Kδ inhibitor with improved safety profile and superior anti-tumor activities in vivo

Journal Articles

SCF^FBXW7/GSK3β-Mediated GFI1 Degradation Suppresses Proliferation of Gastric Cancer Cells

Xiaoling Kuai, Long Li, Ran Chen, Kangjunjie Wang, Min Chen, Binghai Cui, Yuxue Zhang, Junqiang Li, Hongwen Zhu, Hu Zhou, Jianfei Huang, Jun Qin, Zhiwei Wang, Wenyi Wei, Daming Gao

Cancer Res (2019) 79 (17): 4387–4398.

https://doi.org/10.1158/0008-5472.CAN-18-4032

Published: 03 September 2019

View article titled, SCFFBXW7/GSK3β-Mediated GFI1 Degradation Suppresses Proliferation of Gastric Cancer Cells

Includes: Supplementary data

Journal Articles

Abstract 177: Thymidine quinoxaline conjugates as a novel selective and effective photosensitizer for anticancer photodynamic therapy

Qibing Zhou, Zhiwei Wang, Rong Yang, Ting Qian, Dejun Zhang

Cancer Res (2017) 77 (13_Supplement): 177.

https://doi.org/10.1158/1538-7445.AM2017-177

Published: 01 July 2017

View article titled, Abstract 177: Thymidine quinoxaline conjugates as a novel selective and effective photosensitizer for anticancer photodynamic therapy

Journal Articles

Abstract 2597: BGB-3111 is a novel and highly selective Bruton's tyrosine kinase (BTK) inhibitor

Na Li, Zhijian Sun, Ye Liu, Mingming Guo, Yilu Zhang, Dongping Zhou, Bo Zhang, Dan Su, Shuo Zhang, Jing Han, Yajuan Gao, Yunhang Guo, Zhiwei Wang, Min Wei, Lusong Luo, Lai Wang

Cancer Res (2015) 75 (15_Supplement): 2597.

https://doi.org/10.1158/1538-7445.AM2015-2597

Published: 01 August 2015

View article titled, Abstract 2597: BGB-3111 is a novel and highly selective Bruton's tyrosine kinase (BTK) inhibitor

Journal Articles

Curcumin Analogue CDF Inhibits Pancreatic Tumor Growth by Switching on Suppressor microRNAs and Attenuating EZH2 Expression

Bin Bao, Shadan Ali, Sanjeev Banerjee, Zhiwei Wang, Farah Logna, Asfar S. Azmi, Dejuan Kong, Aamir Ahmad, Yiwei Li, Subhash Padhye, Fazlul H. Sarkar

Cancer Res (2012) 72 (1): 335–345.

https://doi.org/10.1158/0008-5472.CAN-11-2182

Published: 02 January 2012

View article titled, Curcumin Analogue CDF Inhibits Pancreatic Tumor Growth by Switching on Suppressor microRNAs and Attenuating EZH2 Expression

Journal Articles

Phosphoglucose Isomerase/Autocrine Motility Factor Mediates Epithelial-Mesenchymal Transition Regulated by miR-200 in Breast Cancer Cells

Aamir Ahmad, Amro Aboukameel, Dejuan Kong, Zhiwei Wang, Seema Sethi, Wei Chen, Fazlul H. Sarkar, Avraham Raz

Cancer Res (2011) 71 (9): 3400–3409.

https://doi.org/10.1158/0008-5472.CAN-10-0965

Published: 29 April 2011

View article titled, Phosphoglucose Isomerase/Autocrine Motility Factor Mediates Epithelial-Mesenchymal Transition Regulated by miR-200 in Breast Cancer Cells

Journal Articles

Abstract 3361: Phosphoglucose isomerase/autocrine motility factor mediates epithelial-mesenchymal transition regulated by miR-200 in breast cancer cells

Aamir Ahmad, Amro Aboukameel, Dejuan Kong, Zhiwei Wang, Avraham Raz, Fazlul H. Sarkar

Cancer Res (2011) 71 (8_Supplement): 3361.

https://doi.org/10.1158/1538-7445.AM2011-3361

Published: 15 April 2011

View article titled, Abstract 3361: Phosphoglucose isomerase/autocrine motility factor mediates epithelial-mesenchymal transition regulated by miR-200 in breast cancer cells

Journal Articles

Abstract 2385: Activated Kras and INK4a/Arf deficiency cooperate to produce pancreatic cancer involved with Notch and NF-κB pathways

Zhiwei Wang, Sanjeev Banerjee, Aamir Ahmad, Asfar S. Azmi, Bin Bao, Shadan Ali, Ramzi M. Mohammad, Lucio Miele, Murray Korc, Fazlul H. Sarkar

Cancer Res (2011) 71 (8_Supplement): 2385.

https://doi.org/10.1158/1538-7445.AM2011-2385

Published: 15 April 2011

View article titled, Abstract 2385: Activated Kras and INK4a/Arf deficiency cooperate to produce pancreatic cancer involved with Notch and NF-κB pathways

Journal Articles

Abstract 173: Targeted killing of cancer stem-like cells by a novel analogue of curcumin

Bin Bao, Shadan Ali, Dejuan Kong, Sanila H. Sarkar, Zhiwei Wang, Sanjeev Banerjee, Amro Aboukameel, Subhash Padhye, Philip A. Philp, Fazlul H. Sarkar

Cancer Res (2011) 71 (8_Supplement): 173.

https://doi.org/10.1158/1538-7445.AM2011-173

Published: 15 April 2011

View article titled, Abstract 173: Targeted killing of cancer stem-like cells by a novel analogue of curcumin

Journal Articles

Gemcitabine Sensitivity Can Be Induced in Pancreatic Cancer Cells through Modulation of miR-200 and miR-21 Expression by Curcumin or Its Analogue CDF

Shadan Ali, Aamir Ahmad, Sanjeev Banerjee, Subhash Padhye, Kristin Dominiak, Jacqueline M. Schaffert, Zhiwei Wang, Philip A. Philip, Fazlul H. Sarkar

Cancer Res (2010) 70 (9): 3606–3617.

https://doi.org/10.1158/0008-5472.CAN-09-4598

Published: 28 April 2010

View article titled, Gemcitabine Sensitivity Can Be Induced in Pancreatic Cancer Cells through Modulation of miR-200 and miR-21 Expression by Curcumin or Its Analogue CDF

Journal Articles

Abstract 5703: Up-regulation of miR-146a contributes to the inhibition of invasion of pancreatic cancer cells

Yiwei Li, Timothy VandenBoom, II, Zhiwei Wang, Dejuan Kong, Shadan Ali, Philip A. Philip, Fazlul H. Sarkar

Cancer Res (2010) 70 (8_Supplement): 5703.

https://doi.org/10.1158/1538-7445.AM10-5703

Published: 15 April 2010

View article titled, Abstract 5703: Up-regulation of miR-146a contributes to the inhibition of invasion of pancreatic cancer cells

Journal Articles

Abstract 4535: MDM2 inhibitor MI-319 in combination with cisplatin/oxaliplatin is an effective treatment for pancreatic cancer independent of p53 function

Asfar S. Azmi, Philip A. Philip, Amro Aboukameel, Sanjeev Banerjee, Zhiwei Wang, Shaomeng Wang, Dajun Yang, Fazlul H. Sarkar, Ramzi M. Mohammad

Cancer Res (2010) 70 (8_Supplement): 4535.

https://doi.org/10.1158/1538-7445.AM10-4535

Published: 15 April 2010

View article titled, Abstract 4535: MDM2 inhibitor MI-319 in combination with cisplatin/oxaliplatin is an effective treatment for pancreatic cancer independent of p53 function

Journal Articles

Abstract 3118: Platelet-derived growth factor-D contributes to aggressiveness of breast cancer cells by up-regulation of Notch and NF-κB signaling pathways

Aamir Ahmad, Dejuan Kong, Zhiwei Wang, Raza Ali, Sanjeev Banerjee, Fazlul H. Sarkar

Cancer Res (2010) 70 (8_Supplement): 3118.

https://doi.org/10.1158/1538-7445.AM10-3118

Published: 15 April 2010

View article titled, Abstract 3118: Platelet-derived growth factor-D contributes to aggressiveness of breast cancer cells by up-regulation of Notch and NF-κB signaling pathways

Journal Articles

Abstract 3803: 3,3-Diindolylmethane enhances Taxotere-induced apoptosis in breast cancer cells through FoXM1 downregulation

KM Rahman, Aamir Ahmad, Shadan Ali, Zhiwei Wang, Seema Sethi, Wael Sakr

Cancer Res (2010) 70 (8_Supplement): 3803.

https://doi.org/10.1158/1538-7445.AM10-3803

Published: 15 April 2010

View article titled, Abstract 3803: 3,3-Diindolylmethane enhances Taxotere-induced apoptosis in breast cancer cells through FoXM1 downregulation

Journal Articles

Abstract 2561: Genistein restored chemosensitivity to oxaliplatin in gemcitabine resistant pancreatic cancer cells in vitro and in orthotopic xenograft mouse model

Sanjeev Banerjee, Zhiwei Wang, Asfar Azmi, Dejuan Kong, Aamir Ahmad, Fazlul H. Sarkar

Cancer Res (2010) 70 (8_Supplement): 2561.

https://doi.org/10.1158/1538-7445.AM10-2561

Published: 15 April 2010

View article titled, Abstract 2561: Genistein restored chemosensitivity to oxaliplatin in gemcitabine resistant pancreatic cancer cells in vitro and in orthotopic xenograft mouse model

Journal Articles

miR-146a Suppresses Invasion of Pancreatic Cancer Cells

Yiwei Li, Timothy G. VandenBoom, II, Zhiwei Wang, Dejuan Kong, Shadan Ali, Philip A. Philip, Fazlul H. Sarkar

Cancer Res (2010) 70 (4): 1486–1495.

https://doi.org/10.1158/0008-5472.CAN-09-2792

Published: 14 February 2010

View article titled, miR-146a Suppresses Invasion of Pancreatic Cancer Cells

Journal Articles

Up-regulation of miR-200 and let-7 by Natural Agents Leads to the Reversal of Epithelial-to-Mesenchymal Transition in Gemcitabine-Resistant Pancreatic Cancer Cells

Yiwei Li, Timothy G. VandenBoom, II, Dejuan Kong, Zhiwei Wang, Shadan Ali, Philip A. Philip, Fazlul H. Sarkar

Cancer Res (2009) 69 (16): 6704–6712.

https://doi.org/10.1158/0008-5472.CAN-09-1298

Published: 12 August 2009

View article titled, Up-regulation of miR-200 and let-7 by Natural Agents Leads to the Reversal of Epithelial-to-Mesenchymal Transition in Gemcitabine-Resistant Pancreatic Cancer Cells

Includes: Supplementary data

Journal Articles

Antitumor Activity of Gemcitabine and Oxaliplatin Is Augmented by Thymoquinone in Pancreatic Cancer

Sanjeev Banerjee, Ahmed O. Kaseb, Zhiwei Wang, Deujan Kong, Mussop Mohammad, Subhash Padhye, Fazlul H. Sarkar, Ramzi M. Mohammad

Cancer Res (2009) 69 (13): 5575–5583.

https://doi.org/10.1158/0008-5472.CAN-08-4235

Published: 01 July 2009

View article titled, Antitumor Activity of Gemcitabine and Oxaliplatin Is Augmented by Thymoquinone in Pancreatic Cancer

NARROW

Abstract 5541: BGB-15025, a potent and selective HPK1 inhibitor, is efficacious as a single agent or in combination with PD-1 antibody in multiple tumor models

Abstract 3077: Preclinical characterization of BGB-11417, a potent and selective Bcl-2 inhibitor with superior antitumor activities in haematological tumor models

Abstract 664: BGB-10188, a highly selective PI3Kδ inhibitor with improved safety profile and superior anti-tumor activities in vivo

SCF^FBXW7/GSK3β-Mediated GFI1 Degradation Suppresses Proliferation of Gastric Cancer Cells

Abstract 177: Thymidine quinoxaline conjugates as a novel selective and effective photosensitizer for anticancer photodynamic therapy

Abstract 2597: BGB-3111 is a novel and highly selective Bruton's tyrosine kinase (BTK) inhibitor

Curcumin Analogue CDF Inhibits Pancreatic Tumor Growth by Switching on Suppressor microRNAs and Attenuating EZH2 Expression

Phosphoglucose Isomerase/Autocrine Motility Factor Mediates Epithelial-Mesenchymal Transition Regulated by miR-200 in Breast Cancer Cells

Abstract 3361: Phosphoglucose isomerase/autocrine motility factor mediates epithelial-mesenchymal transition regulated by miR-200 in breast cancer cells

Abstract 2385: Activated Kras and INK4a/Arf deficiency cooperate to produce pancreatic cancer involved with Notch and NF-κB pathways

Abstract 173: Targeted killing of cancer stem-like cells by a novel analogue of curcumin

Gemcitabine Sensitivity Can Be Induced in Pancreatic Cancer Cells through Modulation of miR-200 and miR-21 Expression by Curcumin or Its Analogue CDF

Abstract 5703: Up-regulation of miR-146a contributes to the inhibition of invasion of pancreatic cancer cells

Abstract 4535: MDM2 inhibitor MI-319 in combination with cisplatin/oxaliplatin is an effective treatment for pancreatic cancer independent of p53 function

Abstract 3118: Platelet-derived growth factor-D contributes to aggressiveness of breast cancer cells by up-regulation of Notch and NF-κB signaling pathways

Abstract 3803: 3,3-Diindolylmethane enhances Taxotere-induced apoptosis in breast cancer cells through FoXM1 downregulation

Abstract 2561: Genistein restored chemosensitivity to oxaliplatin in gemcitabine resistant pancreatic cancer cells in vitro and in orthotopic xenograft mouse model

miR-146a Suppresses Invasion of Pancreatic Cancer Cells

Up-regulation of miR-200 and let-7 by Natural Agents Leads to the Reversal of Epithelial-to-Mesenchymal Transition in Gemcitabine-Resistant Pancreatic Cancer Cells

Antitumor Activity of Gemcitabine and Oxaliplatin Is Augmented by Thymoquinone in Pancreatic Cancer

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only